Sociedad Americana de Hirudoterapia

Clinical reliability of pedicled perforator flaps in the management of adult limb and trunk soft tissue sarcomas: Experience of two French expert centres

Research article published in Journal of plastic, reconstructive & aesthetic surgery : JPRAS (2022)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportEnsayos clínicosLafaye et al. · Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 2022

Abstract

INTRODUCTION: Limb-sparing surgery combined with radiation has become the standard treatment for soft tissue sarcomas. Despite the many advantages of reconstruction procedures, such as muscle-sparing flap and local reconstruction, the use of pedicled perforator flaps remains non-consensual due to doubts about their reliability when associated with radiotherapy. This study evaluated their surgical reliability in reconstructive surgery for limb and trunk soft tissue sarcomas, in terms of healing time, wound disorders, and postoperative complications, regardless of radiation timing. PATIENTS AND METHODS: We realized a retrospective, observational, bi-center study (Cancer University Institute of Toulouse Oncopole, France and Bergonié Institute Bordeaux, France) and describes pedicled perforator flaps performed between January 2015 and January 2021. RESULTS: A total of 74 flaps were included. The median age of the population was 70-year-old. The group consisted of 68.8% (n = 51/74) propeller flaps. We found a partial necrosis rate of 28.4% (n = 21/74), scar disunion of 48.6% (n = 36/74), local infection of 10.8% (n = 8/74), and venous congestion of 13.5% (n = 10/74). Only 16.2% (n = 12/74) required secondary surgical repair to a local complication. The average length of stay was 7.3 days  [1.0-25.0]. The mean operating time of our flaps was 133.4 min [38.0-280.0]. CONCLUSIONS: Pedicled perforator flaps are a surgical technique that can be used in reconstructive surgery for limb and trunk soft tissue sarcomas in adults, regardless of radiation timing. However, these flaps carry a high rate of postoperative complications so they should be reserved for expert surgeons in referral centers.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsHumansAdultAgedPerforator FlapRetrospective StudiesPlastic Surgery ProceduresReproducibility of ResultsSoft Tissue NeoplasmsSarcomaSoft Tissue InjuriesPostoperative Complications

Resumen

Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.

Por qué esto importa para la hirudoterapia

Este estudio retrospectivo, observacional, de dos centros francés evaluó la fiabilidad quirúrgica de colgajos perforantes pediculados en 74 reconstrucciones para sarcomas de tejidos blandos de extremidades y tronco en adultos, reportando una tasa de congestión venosa del 13.5% (n=10/74) junto con necrosis parcial (28.4%), desunión de la cicatriz (48.6%) e infección local (10.8%), y concluyendo que estos colgajos son utilizables independientemente del momento de la radiación, pero con una alta tasa de complicaciones que se maneja mejor en centros de referencia especializados. En cuanto a la hirudoterapia, la relevancia es indirecta pero concreta: la congestión venosa es precisamente la complicación de colgajo fallido para la cual la lombriz medicinal está aprobada por la FDA en microcirugía reconstructiva (K040187), por lo que este estudio ayuda a cuantificar con qué frecuencia surge ese escenario de salvamento en una cohorte real de colgajos. El estudio no utilizó ni evaluó la terapia de lombrices, y como una serie retrospectiva de cohorte única sin comparador, documenta la frecuencia de complicaciones en lugar de cualquier efecto terapéutico.

Citación

Clinical reliability of pedicled perforator flaps in the management of adult limb and trunk soft tissue sarcomas: Experience of two French expert centres.

Lafaye et al. · Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 2022

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 28, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.